Three leading analysts who follow developments within genome editing shared their insights on "GEN Edge Live": Michelle Gilson, a Managing Director with Canaccord Genuity focused on biotechnology; her colleague Arlinda Lee, PhD, a Canaccord Genuity analyst; and Geulah Livshits, PhD, Senior Research Analyst with Chardan covering biotech companies, with a focus on gene editing and oncology.

Joining us on “GEN Edge Live” were: Michelle Gilson, a managing director with Canaccord Genuity focused on biotechnology; her colleague Arlinda Lee, PhD, a Canaccord Genuity analyst; and Geulah Livshits, PhD, senior research analyst with Chardan covering biotech companies, with a focus on gene editing and oncology . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge

Previous articleBiomarkers Found Related to Most Common Type of Leukemia
Next articleEngineered Bacterial Therapeutics Get Boost from PKU Study Data